Jeffrey Capello's Trading History
| NEOGNeogen | Oct 30, 2026 | Director | Uninformative Buy | 21.68K | $506.98K | |
| AGIOAgios Pharma | Jun 23, 2026 | Director | Uninformative Buy | 96.19K | $331.93K | |
| BIIBBiogen | Feb 14, 2020 | EVP & CFO | Uninformative Buy | 432.95K | $790.79K | |
| BSXBoston Scientific | Dec 02, 2013 | EVP & CFO | Informative Sell | 1.27M | $18.77K | |
| TPSTTempest Therapeutics | Mar 20, 2013 | Director | Informative Buy | 100.00K | $5.50K | |
| RVTYRevvity | ― | SVP & CFO | ― | $14.35M | ||
| DCOYDecoy Therapeutics | ― | Director | ― | $0.00 |
You May Also Like
Jeffrey Capello insider profile FAQ
What stocks does Jeffrey Capello hold?
Jeffrey Capello holds: NEOG, BIIB, AGIO, TPST, DCOY, RVTY, BSX stocks.
What was Jeffrey Capello’s latest transaction?
Jeffrey Capello’s latest transaction was an Uninformative Buy of $21.68K.
What is Jeffrey Capello's role in Neogen?
Jeffrey Capello's role in Neogen is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.